Wu et al. showed that lipid dysmetabolism was involved in the development of obesity-related glomerulopathy, and that fatty acid-binding protein 3 (FABP3) (also known as heart-type fatty acid-binding protein or H-FABP) is especially up-regulated in the glomeruli 8. This evidence concerns the gene FABP3 and lipoprotein glomerulopathy.